Won-Ki Cho
Chairman at CHOA PHARMACEUTICAL CO., LTD.
Net worth: 4 M $ as of 29/04/2024
Profile
Won-Ki Cho is currently the Chairman of ChoA Pharmaceutical Co., Ltd.
and Medipharm.
He has an undergraduate degree from Pusan National University and Kyungpook National University, and a doctorate degree from Pukyong National University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 30/03/2023 | 3,464,843 ( 11.18% ) | 4 M $ | 29/04/2024 |
Won-Ki Cho active positions
| Companies | Position | Start |
|---|---|---|
| CHOA PHARMACEUTICAL CO., LTD. | Chairman | 31/12/1987 |
Medipharm
 Medipharm Medical DistributorsDistribution Services Medipharm, founded in 2015, is a cannabis concentrate and derivative product manufacturer based in Seongnam, South Korea. The South Korean company has a good manufacturing practices certified facility with ISO standard-built clean rooms and five primary extraction lines for delivering pure and precision-dosed cannabis products. Medipharm invests in research-driven teams, state-of-the-art technology, and downstream purification methodologies to formulate, develop, process, package, and distribute cannabis extracts and advanced cannabinoid-based products to domestic and international markets. The CEO of the private company is Sung-Hwan Cho. | Chairman | - |
Training of Won-Ki Cho
| Pusan National University | Undergraduate Degree |
| Kyungpook National University | Undergraduate Degree |
| Pukyong National University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| CHOA PHARMACEUTICAL CO., LTD. | Health Technology |
| Private companies | 1 |
|---|---|
Medipharm
Medipharm Medical DistributorsDistribution Services Medipharm, founded in 2015, is a cannabis concentrate and derivative product manufacturer based in Seongnam, South Korea. The South Korean company has a good manufacturing practices certified facility with ISO standard-built clean rooms and five primary extraction lines for delivering pure and precision-dosed cannabis products. Medipharm invests in research-driven teams, state-of-the-art technology, and downstream purification methodologies to formulate, develop, process, package, and distribute cannabis extracts and advanced cannabinoid-based products to domestic and international markets. The CEO of the private company is Sung-Hwan Cho. | Distribution Services |
- Stock Market
- Insiders
- Won-Ki Cho
